Authors:
STASCHKE KA
RICHARDSON KK
MABRY TE
BAXTER AJ
SCHEURING JC
HUFFMAN DM
SMITH WC
RICHARDSON FC
COLACINO JM
Citation: Ka. Staschke et al., DIFFERENTIAL-EFFECTS OF THE INCORPORATION OF OXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-5-IODOURACIL (FIAU) ON THE BINDING OF THE TRANSCRIPTION FACTORS, AP-1 AND TFIID, TO THEIR COGNATE TARGET DNA-SEQUENCES, Nucleic acids research, 24(21), 1996, pp. 4111-4116
Authors:
STASCHKE KA
COLACINO JM
MABRY TE
JONES CD
Citation: Ka. Staschke et al., THE IN-VITRO ANTI-HEPATITIS-B VIRUS ACTIVITY OF FIAU 2'-FLUORO-1-BETA-D-ARABINOFURANOSYL-5-IODO)URACIL] IS SELECTIVE, REVERSIBLE, AND DETERMINED, AT LEAST IN PART, BY THE HOST-CELL, Antiviral research, 23(1), 1994, pp. 45-61
Authors:
BOWSHER RR
COMPTON JA
KIRKWOOD JA
PLACE GD
JONES CD
MABRY TE
HYSLOP DL
HATCHER BL
DESANTE KA
Citation: Rr. Bowsher et al., SENSITIVE AND SPECIFIC RADIOIMMUNOASSAY FOR FIALURIDINE - INITIAL ASSESSMENT OF PHARMACOKINETICS AFTER SINGLE ORAL DOSES TO HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2134-2142